32,000 Shares in LENSAR, Inc. (NASDAQ:LNSR) Acquired by Tabor Asset Management LP

Tabor Asset Management LP acquired a new stake in shares of LENSAR, Inc. (NASDAQ:LNSR - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 32,000 shares of the company's stock, valued at approximately $452,000. Tabor Asset Management LP owned approximately 0.27% of LENSAR at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC increased its holdings in shares of LENSAR by 5.6% in the 4th quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock valued at $948,000 after acquiring an additional 5,627 shares during the last quarter. Draper Asset Management LLC purchased a new position in LENSAR in the 1st quarter valued at approximately $565,000. Renaissance Technologies LLC increased its position in LENSAR by 13.3% during the fourth quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock worth $3,119,000 after buying an additional 40,946 shares in the last quarter. Finally, Huntleigh Advisors Inc. acquired a new stake in shares of LENSAR during the first quarter worth $1,069,000. Institutional investors and hedge funds own 40.15% of the company's stock.

LENSAR Price Performance

Shares of NASDAQ:LNSR opened at $13.32 on Tuesday. The firm has a market capitalization of $157.04 million, a PE ratio of -2.75 and a beta of 0.50. The firm's 50-day moving average is $13.17 and its two-hundred day moving average is $12.55. LENSAR, Inc. has a 1 year low of $3.50 and a 1 year high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($2.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by ($2.16). LENSAR had a negative return on equity of 737.30% and a negative net margin of 99.17%. The business had revenue of $11.53 million for the quarter, compared to analyst estimates of $13.40 million.

Wall Street Analyst Weigh In

LNSR has been the subject of a number of recent analyst reports. Lake Street Capital restated a "hold" rating and set a $15.00 price target (down from $16.00) on shares of LENSAR in a report on Monday, March 24th. BTIG Research cut shares of LENSAR from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 24th.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.